You are here: Industry Insights > COVID-19

News List

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 prnewswire
November 30, 2021
Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.
Chinese mainland reports 21 locally transmitted COVID-19 cases NMPA/Xinhua
November 30, 2021
The Chinese mainland on Nov 28 reported 21 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 29.
India seeks additional data from Serum Institute for Covovax approval Pharmaceutical-Technology
November 30, 2021
The Subject Expert Committee (SEC) on Covid-19 of India’s Central Drugs Standard Control Organisation (CDSCO) has sought more data from the Serum Institute of India (SII) for the Covid-19 vaccine Covovax.
Molnupiravir: Merck’s Covid-19 antiviral less effective in new analysis Pharmaceutical-Technology
November 30, 2021
Merck has provided updated data on its Covid-19 antiviral, molnupiravir, that shows the antiviral to be significantly less effective against the virus than previously thought.
Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research prnasia
November 29, 2021
Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof. Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) ...
I/ITSEC returns to Orlando for in-person 2021 event prnewswire
November 29, 2021
The world's largest modeling, simulation and training conference is back in person as I/ITSEC returns to the Orange County Convention Center in Orlando, Nov. 29-Dec. 3, the National Training and Simulation Association announces.
Government gives nod to commercial export of Covishield and Covaxin in view of sufficient stock ExpressPharma
November 29, 2021
The Union government has allowed commercial export of Covishield and Covaxin considering the sufficient stock of the COVID-19 vaccines available with states and Union Territories as well as with manufacturers, official sources told PTI recently.
India willing to supply Covishield, Covaxin: Mansukh Mandaviya to Latin American, Caribbean envoys ExpressPharma
November 29, 2021
Interacting with ambassadors of Latin American and Caribbean nations, Union Health Minister Mansukh Mandaviya said India is willing to supply Covishield and Covaxin to these countries.
EMA approves Pfizer-BioNTech COVID-19 vaccine for young children PharmaTimes
November 29, 2021
The Food and Drug Administration (FDA) granted approval for emergency use of the Comirnaty vaccine in children in October 2021.
COVID-19 vaccines safe for pregnant women PharmaTimes
November 29, 2021
Data from the UK’s Health Security Agency (UKHSA) has revealed that COVID-19 vaccines are safe in pregnancy.